APPL CRISPR Plasmide
Santa Cruz Biotechnology, Inc. bietet eine Vielzahl von Produkten zur Editierung von Genen an einschließlich CRISPR/Cas9 Knockout und CRISPR Double Nickase Plasmide für das Gen Silencing. APPL Gen Silencer sind erhältlich als APPL CRISPR/Cas9 Knockout Plasmide und APPL Double Nickase Plasmide. APPL CRISPR/dCas9 Aktivierungsplasmide und CRISPR Lenti Aktivierungssysteme für die Aktivierung von Genen sind ebenfalls erhältlich. Gen Silencer und Aktivatoren sind äußerst hilfreich bei der Untersuchung von Genen in Kombination mit den Antikörpern zur Detektion entsprechender Proteine.
APPL CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
APPL1 CRISPR/Cas9 KO Plasmid (h) | sc-402243 | h | Gene Knockout | GFP | 0 | ||
APPL1 HDR Plasmid (h) | sc-402243-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
APPL1 Double Nickase Plasmid (h) | sc-402243-NIC | h | Gene Knockout | Puromycin | 0 | ||
APPL1 Double Nickase Plasmid (h2) | sc-402243-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
APPL1 CRISPR/Cas9 KO Plasmid (m) | sc-428481 | m | Gene Knockout | GFP | 0 | ||
APPL1 HDR Plasmid (m) | sc-428481-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
APPL1 Double Nickase Plasmid (m) | sc-428481-NIC | m | Gene Knockout | Puromycin | 0 | ||
APPL1 Double Nickase Plasmid (m2) | sc-428481-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
APPL2 CRISPR/Cas9 KO Plasmid (h) | sc-402991 | h | Gene Knockout | GFP | 0 | ||
APPL2 HDR Plasmid (h) | sc-402991-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
APPL2 Double Nickase Plasmid (h) | sc-402991-NIC | h | Gene Knockout | Puromycin | 0 | ||
APPL2 Double Nickase Plasmid (h2) | sc-402991-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
APPL2 CRISPR/Cas9 KO Plasmid (m) | sc-432068 | m | Gene Knockout | GFP | 0 | ||
APPL2 HDR Plasmid (m) | sc-432068-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
APPL2 Double Nickase Plasmid (m) | sc-432068-NIC | m | Gene Knockout | Puromycin | 0 | ||
APPL2 Double Nickase Plasmid (m2) | sc-432068-NIC-2 | m | Gene Knockout | Puromycin | 0 |
APPL CRISPR Activation Products
| Empty Table Header | Produkt | Katnr. | Species | Anwendungen | MARKER | Referenzen | Bewertung |
|---|---|---|---|---|---|---|---|
APPL1 CRISPR Activation Plasmid (h) | sc-402243-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 CRISPR Activation Plasmid (h2) | sc-402243-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 Lentiviral Activation Particles (h) | sc-402243-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 Lentiviral Activation Particles (h2) | sc-402243-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 CRISPR Activation Plasmid (m) | sc-428481-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 CRISPR Activation Plasmid (m2) | sc-428481-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 Lentiviral Activation Particles (m) | sc-428481-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL1 Lentiviral Activation Particles (m2) | sc-428481-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 CRISPR Activation Plasmid (h) | sc-402991-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 CRISPR Activation Plasmid (h2) | sc-402991-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 Lentiviral Activation Particles (h) | sc-402991-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 Lentiviral Activation Particles (h2) | sc-402991-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 CRISPR Activation Plasmid (m) | sc-432068-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 CRISPR Activation Plasmid (m2) | sc-432068-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 Lentiviral Activation Particles (m) | sc-432068-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
APPL2 Lentiviral Activation Particles (m2) | sc-432068-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |